oxybutynin has been researched along with Bladder Neck Obstruction in 9 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifteen spina bifida patients, aged between 1 and 12 years, all on a regime of clean intermittent catheterisation (CIC) and oxybutynin since shortly after birth, underwent three consecutive urodynamic studies (UDS)." | 2.71 | Detrusor overactivity in spina bifida: how long does it need to be treated? ( Ab, E; de Jong, TP; Dik, P; Klijn, AJ; van Gool, JD, 2004) |
| "Millions of men suffer from overactive bladder and lower urinary tract symptoms." | 2.44 | Male overactive bladder: the role of urodynamics and anticholinergics. ( MacDiarmid, S; Rogers, A, 2007) |
| "Tadalafil treated bladders measured lower collagen content towards the end of the study, indicating an antifibrotic effect." | 1.42 | Urodynamic improvements following oral medical therapy for partial bladder outlet obstruction in an animal model. ( Maciejewski, CC; Metcalfe, PD; Tredget, EE, 2015) |
| " Our results suggest that the association between an antimuscarinic drug and an antagonist of P2X purinoceptors such as suramin might be helpful to reduce the therapeutic dosage of the antimuscarinic drug, along with its side effects." | 1.33 | Altered neurogenic and mechanical responses to acetylcholine, ATP and substance P in detrusor from rat with outlet obstruction. ( Pinna, C; Puglisi, L; Sanvito, P, 2006) |
| "Management of neuropathic bladder aims to maintain renal function and to secure appliance-free continence; because of recent advances, both objectives are theoretically attainable." | 1.28 | Current management of childhood neuropathic bladder: review of 156 cases. ( Arnold, AJ; Rickwood, AM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babaoglu, M | 1 |
| Zumrutbas, AE | 1 |
| Acar, IC | 1 |
| Hatip, FB | 1 |
| Kucukatay, V | 1 |
| Eskicorapci, S | 1 |
| Aybek, Z | 1 |
| Maciejewski, CC | 1 |
| Tredget, EE | 1 |
| Metcalfe, PD | 1 |
| Polido Júnior, A | 1 |
| Costa, JM | 1 |
| Munhoz, T | 1 |
| Sampaio, FJ | 1 |
| Cardoso, LE | 1 |
| Amaro, JL | 1 |
| Hatanaka, T | 1 |
| Ukai, M | 1 |
| Watanabe, M | 1 |
| Someya, A | 1 |
| Ohtake, A | 1 |
| Suzuki, M | 1 |
| Ueshima, K | 1 |
| Sato, S | 1 |
| Kaku, S | 1 |
| Ab, E | 1 |
| Dik, P | 1 |
| Klijn, AJ | 1 |
| van Gool, JD | 1 |
| de Jong, TP | 1 |
| Pinna, C | 1 |
| Sanvito, P | 1 |
| Puglisi, L | 1 |
| MacDiarmid, S | 1 |
| Rogers, A | 1 |
| Scheepe, JR | 1 |
| de Jong, BW | 1 |
| Wolffenbuttel, KP | 1 |
| Arentshorst, ME | 1 |
| Lodder, P | 1 |
| Kok, DJ | 1 |
| Rickwood, AM | 1 |
| Arnold, AJ | 1 |
1 review available for oxybutynin and Bladder Neck Obstruction
| Article | Year |
|---|---|
Male overactive bladder: the role of urodynamics and anticholinergics.
Topics: Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Cystoscopy; Follow-Up Studies; | 2007 |
1 trial available for oxybutynin and Bladder Neck Obstruction
| Article | Year |
|---|---|
Detrusor overactivity in spina bifida: how long does it need to be treated?
Topics: Child; Child, Preschool; Cholinergic Antagonists; Compliance; Female; Humans; Infant; Infant, Newbor | 2004 |
7 other studies available for oxybutynin and Bladder Neck Obstruction
| Article | Year |
|---|---|
Gap junction expression and the effects of gap junction inhibitors in overactive bladder models: does ovariectomy have a role?
Topics: Analysis of Variance; Animals; Blotting, Western; Carbachol; Connexin 43; Disease Models, Animal; Fe | 2013 |
Urodynamic improvements following oral medical therapy for partial bladder outlet obstruction in an animal model.
Topics: Administration, Oral; Animals; Carbolines; Disease Models, Animal; Female; Mandelic Acids; Muscarini | 2015 |
Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity.
Topics: Animals; Collagen; Elastic Tissue; Male; Mandelic Acids; Models, Animal; Muscle, Smooth; Parasympath | 2010 |
Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Dose-Resp | 2013 |
Altered neurogenic and mechanical responses to acetylcholine, ATP and substance P in detrusor from rat with outlet obstruction.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Atropine; Cholinergic Agonists; Cyclooxygenase Inhib | 2006 |
The effect of oxybutynin on structural changes of the obstructed guinea pig bladder.
Topics: Animals; Disease Models, Animal; Guinea Pigs; Mandelic Acids; Parasympatholytics; Urinary Bladder Ne | 2007 |
Current management of childhood neuropathic bladder: review of 156 cases.
Topics: Adolescent; Child; Child, Preschool; Combined Modality Therapy; Ephedrine; Female; Follow-Up Studies | 1990 |